BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24330704)

  • 1. Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.
    Al-Sharif I; Remmal A; Aboussekhra A
    BMC Cancer; 2013 Dec; 13():600. PubMed ID: 24330704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eugenol modulates genomic methylation and inactivates breast cancer-associated fibroblasts through E2F1-dependent downregulation of DNMT1/DNMT3A.
    Al-Kharashi LA; Bakheet T; AlHarbi WA; Al-Moghrabi N; Aboussekhra A
    Mol Carcinog; 2021 Nov; 60(11):784-795. PubMed ID: 34473867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition.
    Abdullah ML; Al-Shabanah O; Hassan ZK; Hafez MM
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells.
    Al-Hujaily EM; Mohamed AG; Al-Sharif I; Youssef KM; Manogaran PS; Al-Otaibi B; Al-Haza'a A; Al-Jammaz I; Al-Hussein K; Aboussekhra A
    Breast Cancer Res Treat; 2011 Jul; 128(1):97-107. PubMed ID: 20680677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
    Lo WY; Chang NW
    PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
    Wang S; Huang J; Lyu H; Cai B; Yang X; Li F; Tan J; Edgerton SM; Thor AD; Lee CK; Liu B
    Breast Cancer Res; 2013; 15(5):R101. PubMed ID: 24168763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct anti-cancer efficacy of Sapylin on breast cancer cells in vitro and in vivo.
    Zhao G; Ge T; Yang X; Li X
    Hell J Nucl Med; 2016; 19(2):111-7. PubMed ID: 27331203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.
    Abdullah ML; Hafez MM; Al-Hoshani A; Al-Shabanah O
    BMC Complement Altern Med; 2018 Dec; 18(1):321. PubMed ID: 30518369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
    Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
    PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.
    Li T; Zhang Q; Zhang J; Yang G; Shao Z; Luo J; Fan M; Ni C; Wu Z; Hu X
    BMC Cancer; 2014 Feb; 14():96. PubMed ID: 24529079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
    Zhang X; Mukerji R; Samadi AK; Cohen MS
    BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
    Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
    Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tea polyphenols induced apoptosis of breast cancer cells by suppressing the expression of Survivin.
    Chen X; Li Y; Lin Q; Wang Y; Sun H; Wang J; Cui G; Cai L; Dong X
    Sci Rep; 2014 Mar; 4():4416. PubMed ID: 24646833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.
    Laine A; Sihto H; Come C; Rosenfeldt MT; Zwolinska A; Niemelä M; Khanna A; Chan EK; Kähäri VM; Kellokumpu-Lehtinen PL; Sansom OJ; Evan GI; Junttila MR; Ryan KM; Marine JC; Joensuu H; Westermarck J
    Cancer Discov; 2013 Feb; 3(2):182-97. PubMed ID: 23306062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
    De Santi M; Galluzzi L; Lucarini S; Paoletti MF; Fraternale A; Duranti A; De Marco C; Fanelli M; Zaffaroni N; Brandi G; Magnani M
    Breast Cancer Res; 2011 Mar; 13(2):R33. PubMed ID: 21435243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cells.
    Elamin MH; Daghestani MH; Omer SA; Elobeid MA; Virk P; Al-Olayan EM; Hassan ZK; Mohammed OB; Aboussekhra A
    Food Chem Toxicol; 2013 Mar; 53():310-6. PubMed ID: 23261678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of p21 on transcription of survivin in hepatocellular carcinoma HepG2 cells and its regulation mechanism].
    Xiong J; Li YR; Tang ZM; Dou LF; Wang L; Hu LH
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):583-7. PubMed ID: 19102934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.